Global Hospital-acquired Infection Diagnostics Market Research Report 2026(Status and Outlook)
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The global Hospital-acquired Infection Diagnostics market size was estimated at USD 5472.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hospital-acquired Infection Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hospital-acquired Infection Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hospital-acquired Infection Diagnostics market.
Global Hospital-acquired Infection Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Market Segmentation (by Type)
Instrument and Reagents
Consumables
Market Segmentation (by Application)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hospital-acquired Infection Diagnostics Market
Overview of the regional outlook of the Hospital-acquired Infection Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired Infection Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hospital-acquired Infection Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Hospital-acquired Infection Diagnostics market size was estimated at USD 5472.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hospital-acquired Infection Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hospital-acquired Infection Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hospital-acquired Infection Diagnostics market.
Global Hospital-acquired Infection Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Market Segmentation (by Type)
Instrument and Reagents
Consumables
Market Segmentation (by Application)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hospital-acquired Infection Diagnostics Market
Overview of the regional outlook of the Hospital-acquired Infection Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired Infection Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hospital-acquired Infection Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hospital-acquired Infection Diagnostics
1.2 Key Market Segments
1.2.1 Hospital-acquired Infection Diagnostics Segment by Type
1.2.2 Hospital-acquired Infection Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hospital-acquired Infection Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hospital-acquired Infection Diagnostics Product Life Cycle
3.3 Global Hospital-acquired Infection Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hospital-acquired Infection Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hospital-acquired Infection Diagnostics Market Competitive Situation and Trends
3.8.1 Hospital-acquired Infection Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hospital-acquired Infection Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Hospital-acquired Infection Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hospital-acquired Infection Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hospital-acquired Infection Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Hospital-acquired Infection Diagnostics Market Size by Type (2020-2025)
6.4 Global Hospital-acquired Infection Diagnostics Price by Type (2020-2025)
7 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-acquired Infection Diagnostics Market Sales by Application (2020-2025)
7.3 Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
8 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Region
8.2 Global Hospital-acquired Infection Diagnostics Market Size by Region
8.2.1 Global Hospital-acquired Infection Diagnostics Market Size by Region
8.2.2 Global Hospital-acquired Infection Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Hospital-acquired Infection Diagnostics Sales by Country
8.3.2 North America Hospital-acquired Infection Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hospital-acquired Infection Diagnostics Sales by Country
8.4.2 Europe Hospital-acquired Infection Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region
8.5.2 Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hospital-acquired Infection Diagnostics Sales by Country
8.6.2 South America Hospital-acquired Infection Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region
8.7.2 Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Hospital-acquired Infection Diagnostics by Region(2020-2025)
9.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hospital-acquired Infection Diagnostics Production
9.4.1 North America Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hospital-acquired Infection Diagnostics Production
9.5.1 Europe Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hospital-acquired Infection Diagnostics Production (2020-2025)
9.6.1 Japan Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hospital-acquired Infection Diagnostics Production (2020-2025)
9.7.1 China Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
10.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Advan DX
10.2.1 Advan DX Basic Information
10.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Overview
10.2.3 Advan DX Hospital-acquired Infection Diagnostics Product Market Performance
10.2.4 Advan DX Business Overview
10.2.5 Advan DX SWOT Analysis
10.2.6 Advan DX Recent Developments
10.3 Abbott
10.3.1 Abbott Basic Information
10.3.2 Abbott Hospital-acquired Infection Diagnostics Product Overview
10.3.3 Abbott Hospital-acquired Infection Diagnostics Product Market Performance
10.3.4 Abbott Business Overview
10.3.5 Abbott SWOT Analysis
10.3.6 Abbott Recent Developments
10.4 Astrazeneca PLC
10.4.1 Astrazeneca PLC Basic Information
10.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
10.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Market Performance
10.4.4 Astrazeneca PLC Business Overview
10.4.5 Astrazeneca PLC Recent Developments
10.5 Bayer Schering Pharma LLC
10.5.1 Bayer Schering Pharma LLC Basic Information
10.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
10.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Market Performance
10.5.4 Bayer Schering Pharma LLC Business Overview
10.5.5 Bayer Schering Pharma LLC Recent Developments
10.6 Becton Dickinson And Company
10.6.1 Becton Dickinson And Company Basic Information
10.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
10.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Market Performance
10.6.4 Becton Dickinson And Company Business Overview
10.6.5 Becton Dickinson And Company Recent Developments
10.7 Cepheid Inc.
10.7.1 Cepheid Inc. Basic Information
10.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
10.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Market Performance
10.7.4 Cepheid Inc. Business Overview
10.7.5 Cepheid Inc. Recent Developments
10.8 Roche AG
10.8.1 Roche AG Basic Information
10.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Overview
10.8.3 Roche AG Hospital-acquired Infection Diagnostics Product Market Performance
10.8.4 Roche AG Business Overview
10.8.5 Roche AG Recent Developments
10.9 Daiichi Sankyo
10.9.1 Daiichi Sankyo Basic Information
10.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
10.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Market Performance
10.9.4 Daiichi Sankyo Business Overview
10.9.5 Daiichi Sankyo Recent Developments
10.10 Hologic, Inc.
10.10.1 Hologic, Inc. Basic Information
10.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
10.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Market Performance
10.10.4 Hologic, Inc. Business Overview
10.10.5 Hologic, Inc. Recent Developments
11 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast
11.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region
11.2.4 South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hospital-acquired Infection Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hospital-acquired Infection Diagnostics by Type (2026-2035)
12.1.2 Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hospital-acquired Infection Diagnostics by Type (2026-2035)
12.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hospital-acquired Infection Diagnostics
1.2 Key Market Segments
1.2.1 Hospital-acquired Infection Diagnostics Segment by Type
1.2.2 Hospital-acquired Infection Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hospital-acquired Infection Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hospital-acquired Infection Diagnostics Product Life Cycle
3.3 Global Hospital-acquired Infection Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hospital-acquired Infection Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hospital-acquired Infection Diagnostics Market Competitive Situation and Trends
3.8.1 Hospital-acquired Infection Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hospital-acquired Infection Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Hospital-acquired Infection Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hospital-acquired Infection Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hospital-acquired Infection Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Hospital-acquired Infection Diagnostics Market Size by Type (2020-2025)
6.4 Global Hospital-acquired Infection Diagnostics Price by Type (2020-2025)
7 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-acquired Infection Diagnostics Market Sales by Application (2020-2025)
7.3 Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
8 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Region
8.2 Global Hospital-acquired Infection Diagnostics Market Size by Region
8.2.1 Global Hospital-acquired Infection Diagnostics Market Size by Region
8.2.2 Global Hospital-acquired Infection Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Hospital-acquired Infection Diagnostics Sales by Country
8.3.2 North America Hospital-acquired Infection Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hospital-acquired Infection Diagnostics Sales by Country
8.4.2 Europe Hospital-acquired Infection Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region
8.5.2 Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hospital-acquired Infection Diagnostics Sales by Country
8.6.2 South America Hospital-acquired Infection Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region
8.7.2 Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Hospital-acquired Infection Diagnostics by Region(2020-2025)
9.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hospital-acquired Infection Diagnostics Production
9.4.1 North America Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hospital-acquired Infection Diagnostics Production
9.5.1 Europe Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hospital-acquired Infection Diagnostics Production (2020-2025)
9.6.1 Japan Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hospital-acquired Infection Diagnostics Production (2020-2025)
9.7.1 China Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
10.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Advan DX
10.2.1 Advan DX Basic Information
10.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Overview
10.2.3 Advan DX Hospital-acquired Infection Diagnostics Product Market Performance
10.2.4 Advan DX Business Overview
10.2.5 Advan DX SWOT Analysis
10.2.6 Advan DX Recent Developments
10.3 Abbott
10.3.1 Abbott Basic Information
10.3.2 Abbott Hospital-acquired Infection Diagnostics Product Overview
10.3.3 Abbott Hospital-acquired Infection Diagnostics Product Market Performance
10.3.4 Abbott Business Overview
10.3.5 Abbott SWOT Analysis
10.3.6 Abbott Recent Developments
10.4 Astrazeneca PLC
10.4.1 Astrazeneca PLC Basic Information
10.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
10.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Market Performance
10.4.4 Astrazeneca PLC Business Overview
10.4.5 Astrazeneca PLC Recent Developments
10.5 Bayer Schering Pharma LLC
10.5.1 Bayer Schering Pharma LLC Basic Information
10.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
10.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Market Performance
10.5.4 Bayer Schering Pharma LLC Business Overview
10.5.5 Bayer Schering Pharma LLC Recent Developments
10.6 Becton Dickinson And Company
10.6.1 Becton Dickinson And Company Basic Information
10.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
10.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Market Performance
10.6.4 Becton Dickinson And Company Business Overview
10.6.5 Becton Dickinson And Company Recent Developments
10.7 Cepheid Inc.
10.7.1 Cepheid Inc. Basic Information
10.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
10.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Market Performance
10.7.4 Cepheid Inc. Business Overview
10.7.5 Cepheid Inc. Recent Developments
10.8 Roche AG
10.8.1 Roche AG Basic Information
10.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Overview
10.8.3 Roche AG Hospital-acquired Infection Diagnostics Product Market Performance
10.8.4 Roche AG Business Overview
10.8.5 Roche AG Recent Developments
10.9 Daiichi Sankyo
10.9.1 Daiichi Sankyo Basic Information
10.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
10.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Market Performance
10.9.4 Daiichi Sankyo Business Overview
10.9.5 Daiichi Sankyo Recent Developments
10.10 Hologic, Inc.
10.10.1 Hologic, Inc. Basic Information
10.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
10.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Market Performance
10.10.4 Hologic, Inc. Business Overview
10.10.5 Hologic, Inc. Recent Developments
11 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast
11.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region
11.2.4 South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hospital-acquired Infection Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hospital-acquired Infection Diagnostics by Type (2026-2035)
12.1.2 Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hospital-acquired Infection Diagnostics by Type (2026-2035)
12.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hospital-acquired Infection Diagnostics Market Size by Type (M USD)
Table 4. Global Hospital-acquired Infection Diagnostics Market Size by Application
Table 5. Hospital-acquired Infection Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Hospital-acquired Infection Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hospital-acquired Infection Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2025)
Table 11. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hospital-acquired Infection Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hospital-acquired Infection Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hospital-acquired Infection Diagnostics Sales by Type (K Units)
Table 27. Global Hospital-acquired Infection Diagnostics Market Size by Type (M USD)
Table 28. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Hospital-acquired Infection Diagnostics Market Share by Type (2020-2025)
Table 32. Global Hospital-acquired Infection Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Application
Table 34. Global Hospital-acquired Infection Diagnostics Market Size by Application
Table 35. Global Hospital-acquired Infection Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Hospital-acquired Infection Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hospital-acquired Infection Diagnostics Market Share by Application (2020-2025)
Table 39. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Hospital-acquired Infection Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025)
Table 44. North America Hospital-acquired Infection Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hospital-acquired Infection Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hospital-acquired Infection Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hospital-acquired Infection Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Hospital-acquired Infection Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
Table 64. Abbott Laboratories Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Advan DX Basic Information
Table 69. Advan DX Hospital-acquired Infection Diagnostics Product Overview
Table 70. Advan DX Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Advan DX Business Overview
Table 72. Advan DX SWOT Analysis
Table 73. Advan DX Recent Developments
Table 74. Abbott Basic Information
Table 75. Abbott Hospital-acquired Infection Diagnostics Product Overview
Table 76. Abbott Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Business Overview
Table 78. Abbott SWOT Analysis
Table 79. Abbott Recent Developments
Table 80. Astrazeneca PLC Basic Information
Table 81. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
Table 82. Astrazeneca PLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Astrazeneca PLC Business Overview
Table 84. Astrazeneca PLC Recent Developments
Table 85. Bayer Schering Pharma LLC Basic Information
Table 86. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
Table 87. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bayer Schering Pharma LLC Business Overview
Table 89. Bayer Schering Pharma LLC Recent Developments
Table 90. Becton Dickinson And Company Basic Information
Table 91. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
Table 92. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Becton Dickinson And Company Business Overview
Table 94. Becton Dickinson And Company Recent Developments
Table 95. Cepheid Inc. Basic Information
Table 96. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 97. Cepheid Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Cepheid Inc. Business Overview
Table 99. Cepheid Inc. Recent Developments
Table 100. Roche AG Basic Information
Table 101. Roche AG Hospital-acquired Infection Diagnostics Product Overview
Table 102. Roche AG Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Roche AG Business Overview
Table 104. Roche AG Recent Developments
Table 105. Daiichi Sankyo Basic Information
Table 106. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
Table 107. Daiichi Sankyo Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Daiichi Sankyo Business Overview
Table 109. Daiichi Sankyo Recent Developments
Table 110. Hologic, Inc. Basic Information
Table 111. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 112. Hologic, Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Hologic, Inc. Business Overview
Table 114. Hologic, Inc. Recent Developments
Table 115. Global Hospital-acquired Infection Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Hospital-acquired Infection Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Hospital-acquired Infection Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Hospital-acquired Infection Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hospital-acquired Infection Diagnostics Market Size by Type (M USD)
Table 4. Global Hospital-acquired Infection Diagnostics Market Size by Application
Table 5. Hospital-acquired Infection Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Hospital-acquired Infection Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hospital-acquired Infection Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2025)
Table 11. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hospital-acquired Infection Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hospital-acquired Infection Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hospital-acquired Infection Diagnostics Sales by Type (K Units)
Table 27. Global Hospital-acquired Infection Diagnostics Market Size by Type (M USD)
Table 28. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Hospital-acquired Infection Diagnostics Market Share by Type (2020-2025)
Table 32. Global Hospital-acquired Infection Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Application
Table 34. Global Hospital-acquired Infection Diagnostics Market Size by Application
Table 35. Global Hospital-acquired Infection Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Hospital-acquired Infection Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hospital-acquired Infection Diagnostics Market Share by Application (2020-2025)
Table 39. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Hospital-acquired Infection Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025)
Table 44. North America Hospital-acquired Infection Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hospital-acquired Infection Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hospital-acquired Infection Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hospital-acquired Infection Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Hospital-acquired Infection Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Hospital-acquired Infection Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
Table 64. Abbott Laboratories Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Advan DX Basic Information
Table 69. Advan DX Hospital-acquired Infection Diagnostics Product Overview
Table 70. Advan DX Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Advan DX Business Overview
Table 72. Advan DX SWOT Analysis
Table 73. Advan DX Recent Developments
Table 74. Abbott Basic Information
Table 75. Abbott Hospital-acquired Infection Diagnostics Product Overview
Table 76. Abbott Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Business Overview
Table 78. Abbott SWOT Analysis
Table 79. Abbott Recent Developments
Table 80. Astrazeneca PLC Basic Information
Table 81. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
Table 82. Astrazeneca PLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Astrazeneca PLC Business Overview
Table 84. Astrazeneca PLC Recent Developments
Table 85. Bayer Schering Pharma LLC Basic Information
Table 86. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
Table 87. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bayer Schering Pharma LLC Business Overview
Table 89. Bayer Schering Pharma LLC Recent Developments
Table 90. Becton Dickinson And Company Basic Information
Table 91. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
Table 92. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Becton Dickinson And Company Business Overview
Table 94. Becton Dickinson And Company Recent Developments
Table 95. Cepheid Inc. Basic Information
Table 96. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 97. Cepheid Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Cepheid Inc. Business Overview
Table 99. Cepheid Inc. Recent Developments
Table 100. Roche AG Basic Information
Table 101. Roche AG Hospital-acquired Infection Diagnostics Product Overview
Table 102. Roche AG Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Roche AG Business Overview
Table 104. Roche AG Recent Developments
Table 105. Daiichi Sankyo Basic Information
Table 106. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
Table 107. Daiichi Sankyo Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Daiichi Sankyo Business Overview
Table 109. Daiichi Sankyo Recent Developments
Table 110. Hologic, Inc. Basic Information
Table 111. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 112. Hologic, Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Hologic, Inc. Business Overview
Table 114. Hologic, Inc. Recent Developments
Table 115. Global Hospital-acquired Infection Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Hospital-acquired Infection Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Hospital-acquired Infection Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Hospital-acquired Infection Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Hospital-acquired Infection Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hospital-acquired Infection Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-acquired Infection Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Hospital-acquired Infection Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hospital-acquired Infection Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hospital-acquired Infection Diagnostics Product Life Cycle
Figure 13. Hospital-acquired Infection Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hospital-acquired Infection Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Hospital-acquired Infection Diagnostics
Figure 19. Global Hospital-acquired Infection Diagnostics Market PEST Analysis
Figure 20. Global Hospital-acquired Infection Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hospital-acquired Infection Diagnostics Market Share by Type
Figure 27. Sales Market Share of Hospital-acquired Infection Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Hospital-acquired Infection Diagnostics by Type in 2025
Figure 29. Market Share of Hospital-acquired Infection Diagnostics by Type (2020-2025)
Figure 30. Market Share of Hospital-acquired Infection Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hospital-acquired Infection Diagnostics Market Share by Application
Figure 33. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Hospital-acquired Infection Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Hospital-acquired Infection Diagnostics Market Share by Application in 2025
Figure 37. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hospital-acquired Infection Diagnostics Market Size by Country in 2024
Figure 45. U.S. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hospital-acquired Infection Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hospital-acquired Infection Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hospital-acquired Infection Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hospital-acquired Infection Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hospital-acquired Infection Diagnostics Market Size by Country in 2024
Figure 55. Germany Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region in 2024
Figure 68. China Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Hospital-acquired Infection Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Hospital-acquired Infection Diagnostics Market Size by Country in 2024
Figure 82. Brazil Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hospital-acquired Infection Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hospital-acquired Infection Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hospital-acquired Infection Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Hospital-acquired Infection Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Hospital-acquired Infection Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-acquired Infection Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Hospital-acquired Infection Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hospital-acquired Infection Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hospital-acquired Infection Diagnostics Product Life Cycle
Figure 13. Hospital-acquired Infection Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hospital-acquired Infection Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Hospital-acquired Infection Diagnostics
Figure 19. Global Hospital-acquired Infection Diagnostics Market PEST Analysis
Figure 20. Global Hospital-acquired Infection Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hospital-acquired Infection Diagnostics Market Share by Type
Figure 27. Sales Market Share of Hospital-acquired Infection Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Hospital-acquired Infection Diagnostics by Type in 2025
Figure 29. Market Share of Hospital-acquired Infection Diagnostics by Type (2020-2025)
Figure 30. Market Share of Hospital-acquired Infection Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hospital-acquired Infection Diagnostics Market Share by Application
Figure 33. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Hospital-acquired Infection Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Hospital-acquired Infection Diagnostics Market Share by Application in 2025
Figure 37. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hospital-acquired Infection Diagnostics Market Size by Country in 2024
Figure 45. U.S. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hospital-acquired Infection Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hospital-acquired Infection Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hospital-acquired Infection Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hospital-acquired Infection Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hospital-acquired Infection Diagnostics Market Size by Country in 2024
Figure 55. Germany Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region in 2024
Figure 68. China Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Hospital-acquired Infection Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Hospital-acquired Infection Diagnostics Market Size by Country in 2024
Figure 82. Brazil Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hospital-acquired Infection Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hospital-acquired Infection Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hospital-acquired Infection Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hospital-acquired Infection Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hospital-acquired Infection Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Hospital-acquired Infection Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Application (2026-2035)
